Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Heritage Bio Labs

Research Library

Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.

Browse by productGeneral topics

Find articles

Matching articles

Showing 49–60 of 77 articles · Interpret the evidence

Clear search and filters

  • Interpret the evidence

    What a tumor biomarker registry can tell us about MGF

    The term MGF can refer to an insulin-like growth factor 1 splice form or to a synthetic peptide modeled on part of it. A human study registered in September 2025, before the recent publication window, uses MGF-related terminology in a question about blood markers and solid tumors.

    MGF2 sources (2013, 2025)

  • Interpret the evidence

    Why turning on an energy signal did not improve cell repair in one study

    MOTS-c is a peptide encoded in mitochondrial DNA. A 2026 study asked whether exposing human fat-derived stromal cells to MOTS-c could improve their ability to support repair in a mouse model of kidney injury.

    MOTS-C1 source (2026)

  • Interpret the evidence

    What an early cough comparison reported after COVID-19

    MSC exosomes are membrane-bound particles released by mesenchymal stromal cells. They are one category of extracellular vesicle and can contain several kinds of molecules. A 2026 pilot study examined a stromal cell extracellular vesicle preparation in people with persistent cough after COVID-19.

    MSC Exosomes2 sources (2024, 2026)

  • Interpret the evidence

    What expanded access data can reveal about safety

    MSC exosomes are a type of membrane-bound extracellular vesicle from mesenchymal stromal cells. A 2026 report studied an extracellular vesicle-enriched preparation in hospitalized people with respiratory failure due to COVID-19. It used expanded access observations to look at safety.

    MSC Exosomes2 sources (2024, 2026)

  • Interpret the evidence

    Why an exosome study and an FDA approval are separate records

    MSC exosomes are a type of extracellular vesicle released by mesenchymal stromal cells. They are particles with a membrane, rather than a single peptide. In a February 2026 warning letter, the FDA addressed the status of certain products marketed as exosomes for medical purposes.

    MSC Exosomes3 sources (2020–2026)

  • Interpret the evidence

    How mouse muscle separated force from fatigue

    Myostatin, also called GDF8, is a larger signaling protein with a recognized role in limiting muscle size. A 2026 study in mice asked whether muscle with higher myostatin expression also used energy differently and resisted fatigue during repeated contractions.

    Myostatin1 source (2026)

  • Interpret the evidence

    What a 2026 Cesarean Delivery Study Compared About Blood Loss

    Oxytocin stimulates uterine contractions, one reason it is studied and used in obstetric care. A 2026 clinical trial compared oxytocin with carbetocin, a related but distinct uterotonic, with or without a medicine called tranexamic acid.

    Oxytocin2 sources (2026)

  • Interpret the evidence

    Why Oxytocin’s Pain Findings Depended on the Experimental Context

    Oxytocin is one such peptide hormone, studied for possible effects on fear, stress and the experience of pain. A randomized 2026 study asked whether the response to an experimental painful stimulus changed depending on the emotional context.

    Oxytocin1 source (2026)

  • Interpret the evidence

    What a Rat Navigation Study Can Tell Us About Pinealon and Learning

    Pinealon, also called EDR, is a three-amino-acid peptide. An older study examined how young and old rats performed on a navigation task after exposure to Pinealon or a different preparation.

    Pinealon1 source (2013)

  • Interpret the evidence

    Why the Bremelanotide Extension Study Cannot Replace a Placebo Comparison

    PT-141, or bremelanotide, had a 52-week extension after the controlled phase of the RECONNECT studies. The older extension is the direct source for this comparison of study designs. Its results should be read alongside the current US labeling.

    PT-1412 sources (2019, 2026)

  • Interpret the evidence

    Why glucose averages leave a combination safety question open

    Retatrutide is an investigational peptide that activates GIP, GLP-1 and glucagon receptors. IGF-1 LR3 is a modified growth-factor protein with an extended amino-acid sequence.

    RETA / IGF-1 LR33 sources (1997–2026)

  • Interpret the evidence

    What a different retatrutide combination taught researchers about study design

    Retatrutide is an investigational GIP, GLP-1 and glucagon receptor agonist. IGF-1 LR3 is a modified, extended insulin-like growth factor protein. The exact pair in this entry is separate from a 2026 rat experiment that tested retatrutide with cagrilintide, an amylin-based peptide.

    RETA / IGF-1 LR32 sources (1992, 2026)

Browse by product

General topics

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Library index (JSON)